RNF213 and multiminicore myopathy: Among the 20 patients with predicted deleterious and possibly deleterious RNF213 variants (referred to as “RNF213 patients”, Table S4, Fig. 2B), 17 presented with MMD (31% of all MMD patients; Fig. 1, left).